MedTrace Logo

EIMD and Microgreens

NCT07774221 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-08-19

No results posted yet for this study

Summary

This study investigated whether a mixed microgreens intervention could modulate biochemical responses to strenuous eccentric exercise. The findings suggest that microgreens consumption was associated with lower post-exercise levels of several muscle damage and inflammatory biomarkers, particularly CK, LDH, AST, TNF-α, and CRP, while effects on myoglobin and IL-6 were limited. Further controlled studies are needed to confirm these findings and clarify their biological significance.

Conditions

  • Exercise-Induced Muscle Stress

Interventions

DIETARY_SUPPLEMENT

Mixed Microgreens and Wheatgrass Juice

Participants received a mixed preparation of black radish, red radish, broccoli, and kale microgreens at a total daily dose of 60 g, divided into three 20-g administrations consumed in the morning, at noon, and in the evening. Participants also consumed 30 mL of wheatgrass juice each morning during the intervention period. The intervention was administered over four cycles, with each cycle consisting of 5 consecutive days followed by a 2-day interval. The final intervention cycle coincided with the exercise period.

DIETARY_SUPPLEMENT

Lettuce

Participants assigned to the control group received lettuce as the control green food according to the study protocol and underwent the same exercise and assessment procedures as the intervention group.

Sponsors & Collaborators

  • Çanakkale Onsekiz Mart University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-05
Primary Completion
2026-01-06
Completion
2026-12-14

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07774221 on ClinicalTrials.gov